Enzymatic Pulp Bleaching Patents: Top Companies & Filing Trends 2026
A data-backed look at enzymatic pulp bleaching patents: 546 records, filing trends from 2015 through 2026, assignee concentration, and IPC technology composition across pulp treatment, enzyme engineering and bleaching cl
Filing growth = 2021 (15 records) → 2024 (5); 2024 is the last year we treat as complete. Top-5 share = the 5 largest assignees ÷ all 546 records in scope (CR5), not the ranked leaders only.
What this landscape covers
This landscape draws on 546 published patent records filed or published between 2015 and the 2026 data cut-off, covering enzymatic treatment of pulp for bleaching, deinking and papermaking applications. The scope spans both the enzyme layer — genetically engineered microorganisms and fermentation-derived enzymes — and the process layer, where those enzymes are applied to pulp stock, wet lap or dried pulp before or during papermaking.
Records are drawn from receiving offices including the EPO, WIPO's PCT route, the United States, Finland, Canada and Australia, giving a cross-jurisdiction view of where this activity is being protected rather than a single-country snapshot.
Filing activity and technology composition
The dataset spans 546 published records from 2015 through the 2026 cut-off, tracked across receiving offices including the EPO, WIPO, the United States, Finland, Canada and Australia.
Filing trend: a 2020 peak, then a step down
Filings rose from 14 in 2017 to a peak of 26 in 2020, then fell from 15 in 2021 to 5 in 2024 — a 67% drop over that three-year span. Because publication lags filing by roughly 18 months, 2025 and 2026 figures are still incomplete and should not be read as a continuation of that decline.
Publication lags filing by roughly 18 months, so 2025 onwards are still filling in. Growth rates on this page therefore end at 2024; running them to the last bar would understate the field.
Technology composition: pulp treatment dominates, bleaching itself is narrow
D21C pulp production and treatment covers 61.5% of the 546 records, with C12N microorganism and genetic-engineering claims close behind at 36.4%. Dedicated bleaching and dry-cleaning claims under D06L make up just 6.2%, meaning most of the field's claim density sits in the treatment and enzyme layers rather than in bleaching as a standalone category.
Shares are the percentage of the 546 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
Go deeper on Pulp & Papermaking: Enzymatic Pulp Bleaching Patent Landscape with Eureka
This page is one run against one query. Ask Eureka your own question about pulp & papermaking: enzymatic pulp bleaching patent landscape and every answer comes back with the patent numbers behind it.
Try EurekaRepresentative filing and most-cited prior art
Enzymatic pre-treatment of market pulp to improve fiber drainage and physical properties
Methods for reducing the effects of wetlapping, drying, and hornification of pulp fibers, increasing pulp drainage and strength properties in the final paper product. The method creates a value-added product for the wastepaper supplier or at the pulp and/or deinking mill — treating a wastepaper load, wet pulp stock, wet lap, or dried pulp with enzymes that enhance pulp or paper quality when repulped and processed at the paper mill.Granted 2020-07-21 to Enzymatic Deinking Technologies, L.L.C.


| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | WO1994012621A1 | Enhancement of enzyme reactions | 652 |
| 2 | WO1995001426A1 | Enhancement of laccase reactions | 589 |
| 3 | US6066233A | Method of improving pulp freeness using cellulase and pectinase enzymes | 99 |
| 4 | US20080060774A1 | Paperboard containing microplatelet cellulose particles | 93 |
| 5 | WO2008036061A2 | Enzymes and formulations for broad-specificity decontamination of chemical and biological warfare agents | 85 |
| 6 | US20090118477A1 | Continuous counter-current organosolv processing of lignocellulosic feedstocks | 75 |
| 7 | WO1994012619A1 | Enhancement of enzyme reactions | 67 |
| 8 | WO1994012620A1 | Enhancement of enzyme reactions | 67 |
| 9 | US20090155238A1 | Xylanases, nucleic acids encoding them and methods for making and using them | 65 |
| 10 | US5691193A | Non-chlorine bleaching of kraft pulp | 65 |
Citation counts favour older records in the searched corpus and should be read as a signal of influence, not current importance.
Each row carries its publication number; clicking a row searches Eureka by that number.
Put your own technology through the same analysis
Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →MCP server & REST API
When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →What the data means for strategy
Three findings shape where to file, who to watch, and where prior art risk is concentrated.
Filing activity is concentrated at the top
The leading assignee holds 40 records on its own, and the top 5 combined account for 30.0% of the 546 records in scope. The top 10 extend that to 48.4%, leaving the remaining 90 ranked assignees to split the rest — a classic leader-plus-long-tail structure.
Activity has cooled since the 2020 peak
Filings rose to a peak of 26 in 2020, then declined from 15 in 2021 to 5 in 2024. Publication lag means 2025–2026 counts are still filling in, so this should be read as a cooling from peak rather than a confirmed long-term decline.
Pulp treatment, not bleaching itself, is the dense zone
D21C pulp production and treatment claims appear in 61.5% of the 546 records, versus just 6.2% for dedicated bleaching and dry-cleaning claims under D06L. Most patent value sits in the treatment and enzyme layers upstream of the bleaching step.
Cross-institution filing is rare and clustered
Only 10 co-assignee pairs appear across the dataset, with the strongest pairing linked to 25 shared records between a national research institute and an energy-research partner. Collaboration outside that small cluster is limited.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to pulp & papermaking: enzymatic pulp bleaching patent landscape, with the prior art for and against each one.
| Assignee | Co-assignee | Shared families |
|---|---|---|
| National Institute of Agronomic Research (INRA) | IFP Energies Nouvelles | 25 |
| Novo Nordisk A/S | SCA WIFSTA OSTRAND | 16 |
| National Institute of Agronomic Research (INRA) | VTT Technical Research Centre of Finland Ltd | 8 |
| National Institute of Agronomic Research (INRA) | University of Provence | 8 |
| IFP Energies Nouvelles | VTT Technical Research Centre of Finland Ltd | 8 |
| IFP Energies Nouvelles | University of Provence | 8 |
| Verenium Corporation | BP Corporation North America Inc. | 5 |
| Iogen Bio-Products Corporation | POPOVICI CORINA | 5 |
The strongest co-assignee pairing links a national agronomic research institute with an energy-research partner across 25 shared records — a research-institute-to-industry pattern rather than broad industry consolidation.
Where to take this analysis
The dataset points to a concentrated leadership group, a cooling filing trend still working through publication lag, and thin claim coverage at the edges of the classification spread.
Check freedom-to-operate against the leaders
With the top 5 assignees holding 30.0% of the 546 records, a targeted claim-chart review of those portfolios is the fastest way to surface real prior art risk before committing to a formulation.
Run an FTO search in EurekaScope a filing into the thin branches
C11D, C12R and D06L each sit well below the D21C pulp-treatment core, and only 10 co-assignee pairs exist across the whole dataset — narrow, specific claims here face less crowded prior art.
Draft a claim scope in EurekaWatch the 2025–2026 filings as they publish
The apparent decline to 5 filings in 2024 is real, but 2025 and 2026 records are still incomplete because of publication lag — recheck this trend once those years fill in.
Track filing trends in EurekaCommon questions on enzymatic pulp bleaching patents
The assignee ranking covers 100 companies drawn from the 546 records in scope, and it is concentrated at the top: the leading assignee holds 40 records, and the top 5 combined account for 30.0% of all 546 records. That leaves a long tail of smaller filers and single-record entrants below the top 10, which together hold 48.4% of the field. Anyone doing freedom-to-operate work should focus first on the leaders rather than the tail, since claim density is heaviest there.
Filings peaked at 26 records in 2020 and fell to 5 by 2024, a 67% decline over that three-year span. However, because patent publication typically lags filing by around 18 months, the 2025 and 2026 figures in this dataset are still incomplete and cannot yet be read as confirmation of a continued slowdown. The safest reading is that activity cooled from its 2020 peak, without drawing conclusions about the most recent one to two years.
D21C, covering pulp production and treatment, appears in 61.5% of the 546 records and is the largest single classification. C12N, covering microorganisms and genetic engineering, follows at 36.4%, reflecting how much of the field's activity is upstream enzyme development rather than the bleaching step itself. Dedicated bleaching and dry-cleaning claims under D06L are comparatively narrow at 6.2%, which is useful context if you assumed bleaching-specific claims were the field's centre of gravity.
US10718088B2, assigned to Enzymatic Deinking Technologies, covers enzymatic pre-treatment of market pulp applied before wetlapping, drying or repulping, aimed at improving fibre drainage and strength in the final paper product. Its scope is tied to that specific process timing and outcome, so work that applies enzymes at a different process stage or targets a different property, such as brightness, likely falls outside its literal claims. It remains a useful reference point for anyone building a deinking or fibre-recovery process to check against.
The thinnest branches relative to the 546-record total are C11D detergent and cleaning compositions at 7.5%, C12R microorganism indexing at 6.4%, and D06L bleaching-specific claims at 6.2%, all far below the D21C pulp-treatment core at 61.5%. Only 10 co-assignee pairs appear across the entire dataset, indicating limited cross-institution collaboration outside a small cluster. A specific combination claim tying an enzyme class to a defined detergent carrier at a stated bleaching stage is one plausible way to file into that space without colliding with the dense pulp-treatment prior art.
Research Pulp & Papermaking: Enzymatic Pulp Bleaching Patent Landscape in depth with Eureka
Go past this page: query the whole pulp & papermaking: enzymatic pulp bleaching patent landscape corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company’s registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.